Maximize Clinical Efficacy with PrecisePK

PrecisePK combines extensive research from well-validated clinical trials with real-time patient data to help you obtain precise and individualized dosing regimens.
Auto-Selection of Best Fit Models:
Based on the patient's profile, the model that best fits the patient’s characteristics will be auto-selected and the associated PK parameters will be shown.
User Control and Moderation:
Explore different models and choose the one that best suits your case. Freely edit calculated PK parameters based on your clinical knowledge of the patient.
Unique Patient Profiles
Input details, past labs results and unique patient characteristics to create a patient’s individualized profile.
Auto-Selection of Best Fit Models
Based on the patient's profile, the model that best fits the patient’s characteristics will be auto-selected and the associated PK parameters will be shown.
User Control and Moderation
Explore different models and choose the one that best suits your case. Freely edit calculated PK parameters based on your clinical knowledge of the patient.
Individualized Dosage Recommendations:
Choose desired therapeutic treatment target and receive efficient and practical dose recommendations within a few clicks.
Continuous AUC Monitoring:
Auto-update next dosage date and time based on chosen intervals. Set a regimen by adding multiple doses at once and keep the model informed with patient data and receive individualized recommendations.
Interactive Graph:
Serum level graph allows you to hover over for detailed measurements at any point, zoom in on certan time periods, click and drag to measure AUC and toggle specific indicators on/off.
Individualized Dosage Recommendations:
Choose desired therapeutic treatment target and receive efficient and practical dose recommendations within a few clicks.
Continuous AUC Monitoring
Auto-update next dosage date and time based on chosen intervals. Set a regimen by adding multiple doses at once and keep the model informed with patient data and receive individualized recommendations.
Interactive Graph
Serum level graph allows you to hover over for detailed measurements at any point, zoom in on certan time periods, click and drag to measure AUC and toggle specific indicators on/off.
Customizable Nomogram:
Explore flexible regimen options that fit your patient's needs and achieve therapeutic targets.
Target Evaluation:
Project overall drug exposure results and compare individual and population models. Receive toxicity warning alerts when one or more parameters are outside the recommended range.
Customizable Nomogram
Explore flexible regimen options that fit your patient's needs and achieve therapeutic targets.
Target Evaluation
Project overall drug exposure results and compare individual and population models. Receive toxicity warning alerts when one or more parameters are outside the recommended range.
Interactive Graph
Serum level graph allows you to hover over for detailed measurements at any point, zoom in on certan time periods, click and drag to measure AUC and toggle specific indicators on/off.

Do More with PrecisePK's
Bayesian-Guided AUC Dosing.

Create tailored patient profiles to account for unique patient characteristics.
Easily account for unique patient characteristics such as critical illness, obesity, amputation and more. Relevant PK parameters will automatically be adjusted with the selection of these characteristics.
Pair your clinical judgement with our science and research.
Based on a patient’s profile, PrecisePK  automatically assigns  a population model that best fits their characteristics. For added flexibility, select different population models or edit calculated PK parameters according to your clinical judgement.
Integrate machine-learning with clinical results to customize dosing for each patient.
With the addition of patient-specific serum concentration levels, our program learns and improves its calculations. As a result, dosing recommendations become highly individualized for each patient.
Minimize the risk of toxicity through data-driven prediction.
Plan ahead effectively by viewing serum levels and drug exposure predictions based on specified dosing regimens. Quickly receive toxicity warnings and evaluate how to help your patients reach therapeutic targets.
How Will PrecisePK 
Integrate Into My Workflow?
With 30+ years of clinical experience and continuous research and development, PrecisePK integrates seamlessly and securely into your everyday workflow. We ensure the highest degree of safety and standard of support to bring you an optimal clinical experience.
Unlimited 1-on-1 onboarding training sessions
Unlimited Technical & Clinical support
Effortless account and license management
Collaboration featuring a shared database across institutions
Encrypted database & Security protocols
Compatible with any modern browser
Ever-Growing
Drug Models
PrecisePK’s in-house pharmacists transfer evidence-based literature to clinically-validated PK/PD models to develop each drug model based on the latest guidelines.
Current Offerings
Amikacin
Ciprofloxacin
Digoxin
Flucytosine
Gentamicin
Lithium
Phenobarbital
Levofloxacin/ofloxacin
Phenytoin, Michaelis-Menten elimination
Procainamide
Quinidine
Theophylline (or aminophylline)
Tobramycin
Valproic acid
Voriconazole
Vancomycin
In Development
Tacrolimus
Methotrexate
Carboplatin
Busulfan
Cyclosporine
Ever-Growing Drug Package
PrecisePK excels in all age groups, including neonates, pre-term infants, and children. Certain conditions such as ICU/critically ill status, burns, pregnancy, dialysis, and obesity are also accounted for.
Models available for:
pediatric
neonate
adult patients
Models available for:

Models available for:

neonate
pediatric
adult patients

Models available for:

adult patients

neonate

pediatric

All-inclusive Drug Bundles & Associated Population Models

Vancomycin
Antifungal
Lithium
Aminoglycosides
Anticonvulsants
Antibiotics
PrecisePK Helps You
1
Maximize clinical efficiency by saving time and reducing workload for complex calculations.
With just a few clicks, clinical pharmacists can receive practical and individualized dosage recommendations.
2
Save lives by better reaching therapeutic targets faster and reducing toxicity incidences.
By tailoring dosage recommendations to individual patients and using our Prediction features, therapeutic targets can be reached more efficiently and safely.
3
Save on costs by preventing ADEs, avoiding malpractice claims and reducing extended hospital stays.
Therapeutic Drug Monitoring helps your institution cut back on a multitude of indirect costs.
4
Fully comply with industry standard guidelines, such as the 2020 ASHP/IDSA Vancomycin Guidelines.
Per the latest guidelines, AUC-based monitoring is preferred over trough-based monitoring as the most accurate and optimal way to manage vancomycin dosing. PrecisePK uses Bayesian principles to accurately and easily calculate AUC.
Don't Just Take Our Word For It.
Learn more about the benefits of using therapeutic drug monitoring systems and vancomycin AUC24 Bayesian software.

$60,305

savings per year for using AUC24 Vancomycin Bayesian-Based Dosing

Paul E Sabourenkov, MBioinf, Robert C McLeay, PhD, 1599. AUC24 Vancomycin Bayesian-Based Dosing:Increasing Therapeutic Target Attainment with DecreasedTDM Cost, Open Forum Infectious Diseases, Volume 6,Issue Supplement_2, October 2019, Page S583, https://doi.org/10.1093/ofid/ofz360.1463

10 days

reduced length of hospital stay per patient using TDM guidance

Paul E Sabourenkov, MBioinf, Robert C McLeay, PhD, 1599. AUC24 Vancomycin Bayesian-Based Dosing: Increasing Therapeutic Target Attainment with DecreasedTDM Cost, Open Forum Infectious Diseases, Volume 6,Issue Supplement_2, October 2019, Page S583, https://doi.org/10.1093/ofid/ofz360.1463

$376,500

savings of malpractice claims due to preventable inpatient ADEs

Rothschild JM, Federico FA, Gandhi TK, Kaushal R,Williams DH, Bates DW. Analysis of Medication-Related Malpractice Claims: Causes, Preventability, and Costs. Arch Intern Med. 2002;162(21):2414–2420.
doi:10.1001/archinte.162.21.2414

up to

52:1

in benefit-to-cost from using a TDM software (aminoglycosides)

Schumacher GE, Barr JT. Economic and outcome issues for therapeutic drug monitoring in medicine. TherDrug Monit. 1998;20(5):539‐542.
doi:10.1097/00007691-199810000-00016

up to

$2,600

savings in preventable ADEs per patient

Rothschild JM, Federico FA, Gandhi TK, Kaushal R, Williams DH, Bates DW. Analysis of Medication-Related Malpractice Claims: Causes, Preventability, and Costs. Arch Intern Med. 2002;162(21):2414–2420.
doi:10.1001/archinte.162.21.2414

10.5%

reduction in the incidence of nephrotoxicity from using a TDM software (aminoglycosides)

van Lent-Evers NA, Mathôt RA, Geus WP, van Hout BA,Vinks AA. Impact of goal-oriented and model-basedclinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis. TherDrug Monit. 1999;21(1):63‐73.
doi:10.1097/00007691-199902000-00010

Optimize Your Clinical Experience with PrecisePK.